Hey there, web surfer!

To search and monitor rising trends,
create an account here. It's free.

Join Treendly

live demand report in US

Wegovy

Health   Product    đź‘€ Early     


Wegovy is a prescription medication used for weight management in adults with obesity or overweight with at least one weight-related condition. It contains semaglutide, a synthetic version of a hormone called glucagon-like peptide-1 (GLP-1) that regulates appetite and blood sugar levels.

  

Track this trend
(Monitor this trend over time)
 12 Months
Trend: growing
MOM change: 0.47%
 5 Years
Trend: growing
MOM change: 2.41%

Top reasons why this topic is getting popular

1. Effective Weight Loss

Wegovy has been shown to be highly effective in promoting weight loss. In clinical trials, patients taking Wegovy lost an average of 15-20% of their body weight, compared to 2-5% with a placebo.

2. Convenient Administration

Wegovy is administered once a week via a subcutaneous injection, making it a convenient option for those who struggle with daily medication adherence or frequent doctor visits.

3. Improved Health Outcomes

Wegovy has been shown to improve several health outcomes in addition to weight loss, including reduced blood pressure, improved blood sugar control, and decreased risk of cardiovascular disease.

4. Prescription-Only

Wegovy is a prescription-only medication, which means it can only be obtained with a doctor's prescription. This helps ensure that patients are properly screened for potential side effects and that the medication is used appropriately.

5. Growing Popularity

As obesity rates continue to rise, there is a growing demand for effective weight loss medications like Wegovy. This has led to increased awareness and popularity of the medication among healthcare providers and patients alike.

Who's talking about this trend?

1. Katerina Schneider (@katerinaschneider)

Wegovy ambassador and founder of the supplement company 'Ritual' who frequently shares her experience with Wegovy on her Instagram account.

2. Dr. Holly Fennel (@drhollyfennel)

Doctor and influencer who frequently shares her knowledge and experience with Wegovy on her Instagram account.

3. Kris Carr (@kriscarr)

Best-selling author, wellness activist, and influencer who frequently shares her journey and experience with Wegovy on her Instagram account.

4. Tanya Zuckerbrot (@tanyazuckerbrot)

Registered dietitian and influencer who frequently shares information and tips about weight loss medication, including Wegovy, on her Instagram account.

5. Dr. Adrienne Youdim (@dradrienneyoudim)

Board-certified internist and medical weight loss specialist who frequently shares her expertise and experience with Wegovy on her Instagram account.

Latest forum discussions

We tracked 3022 total in the last 3 months

via More employers could cover popular weight loss and diabetes drugs like Ozempic and Wegovy in 2024, allowing workers to avoid steep out-of-pocket costs, a new survey found. article source
Published on 2023-10-12 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Just a few short weeks after Wegovy posted a major cardio outcomes win, Novo Nordisk has chalked up another heart-related victory for its semaglutide star. In the phase 3 study STEP HFpEF, semaglutide 2.4 mg (Wegovy’s dose) bested placebo at reducing symptoms and physical limitations in patients with obesity and heart failure with preserved ejection fraction (HFpEF). article source
Published on 2023-08-25 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Just a few short weeks after Wegovy posted a major cardio outcomes win, Novo Nordisk has chalked up another heart-related victory for its semaglutide star. In the phase 3 study STEP HFpEF, semaglutide 2.4 mg (Wegovy’s dose) bested placebo at reducing symptoms and physical limitations in patients with obesity and heart failure with preserved ejection fraction (HFpEF). article source
Published on 2023-08-25 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... analysis on data from the Wegovy trial on cardiovascular outcomes reveals... semaglutide, sold under brand names Wegovy and Ozempic, resulted in a...
Published on 2023-08-31 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... analysis on data from the Wegovy trial on cardiovascular outcomes reveals... semaglutide, sold under brand names Wegovy and Ozempic, resulted in a...
Published on 2023-08-31 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Novo Nordisk (NOVOb.CO) has hired U.S. private contract manufacturer PCI Pharma Services to handle assembly and packaging of Wegovy, a source familiar with the matter said, as it races to boost output of the weight-loss drug to meet demand. article source
Published on 2023-09-18 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Novo Nordisk (NOVOb.CO) has hired U.S. private contract manufacturer PCI Pharma Services to handle assembly and packaging of Wegovy, a source familiar with the matter said, as it races to boost output of the weight-loss drug to meet demand. article source
Published on 2023-09-18 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via After three months of Novo Nordisk restricting supply to lower doses of its popular weight loss drug Wegovy, the company said Aug. 10 it will continue to limit its supply. article source
Published on 2023-08-10 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via After three months of Novo Nordisk restricting supply to lower doses of its popular weight loss drug Wegovy, the company said Aug. 10 it will continue to limit its supply. article source
Published on 2023-08-10 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... fast-growing weight loss drug, Wegovy, for which demand has outstripped...
Published on 2023-08-30 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
... fast-growing weight loss drug, Wegovy, for which demand has outstripped...
Published on 2023-08-30 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via A source told the outlet that Thermo Fisher is filling Wegovy injection pens at its facility in Greenville, North Carolina but it was not clear how much the factories are producing. article source
Published on 2023-08-23 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via A source told the outlet that Thermo Fisher is filling Wegovy injection pens at its facility in Greenville, North Carolina but it was not clear how much the factories are producing. article source
Published on 2023-08-23 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought by a generic drugmaker that is hoping to sell generic versions of the blockbuster medications. article source
Published on 2023-10-03 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought by a generic drugmaker that is hoping to sell generic versions of the blockbuster medications. article source
Published on 2023-10-03 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Novo Nordisk has launched Wegovy (semaglutide injection) as an adjunctive treatment for obese patients in the UK. The latest move is aimed at sharing the government’s objective to make obesity care accessible to patients with high unmet medical need. article source
Published on 2023-09-05 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
via Novo Nordisk has launched Wegovy (semaglutide injection) as an adjunctive treatment for obese patients in the UK. The latest move is aimed at sharing the government’s objective to make obesity care accessible to patients with high unmet medical need. article source
Published on 2023-09-05 in the Pharma/Biotech Companies - In the News forum
This discussion is in English.
Why the he** can’t your company keep up with producing the smaller doses of Wegovy?? If you produce any where the he** are they going that there is this shortage? I’ve been waiting over 2 months and still haven’t got mine available at my pharmacy!!
Published on 2023-08-14 in the Novo Nordisk forum
This discussion is in English.
Why the he** can’t your company keep up with producing the smaller doses of Wegovy?? If you produce any where the he** are they going that there is this shortage? I’ve been waiting over 2 months and still haven’t got mine available at my pharmacy!!
Published on 2023-08-14 in the Novo Nordisk forum
This discussion is in English.